CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

pgt121

mAbexperimental

Clinical trial activity

13 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
11
Phase 2
5
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2016 (NCT02960581)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • pgt121

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06987318Phase 1Feb 15, 2026Monogram Biosciences, National Institute of Allergy and Infectious Diseases (NIAID)
NCT06812494Phase 2Feb 1, 2025Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
NCT06517693Phase 1Nov 1, 2024National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health (NIMH), National Institutes of Health (NIH), University of California, Irvine
NCT06508749Phase 1/Phase 2 (Phase 2)Oct 17, 2024National Institute of Allergy and Infectious Diseases (NIAID)
NCT05719441Phase 2Feb 1, 2024National Institute of Allergy and Infectious Diseases (NIAID)
NCT05959707Phase 1Oct 14, 2023HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina at Chapel Hill
NCT05184452Phase 1Nov 15, 2021Centre for the AIDS Programme of Research in South Africa, Department of Health and Human Services, Emory University, George Washington University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
NCT04983030Phase 1/Phase 2 (Phase 2)Aug 1, 2021Harvard University, Janssen Pharmaceutica NV, National Institute of Allergy and Infectious Diseases (NIAID), Orlando Immunology Center, University of Texas at Houston
NCT04212091Phase 1Feb 10, 2020Emory University, Harvard University, HIV Prevention Trials Network, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina at Chapel Hill
NCT03928821Phase 1Jun 30, 2019Columbia University, National Institute of Allergy and Infectious Diseases (NIAID)
NCT03721510Phase 1/Phase 2 (Phase 2)Dec 3, 2018Harvard University, International AIDS Vaccine Initiative, National Institute of Allergy and Infectious Diseases (NIAID), Orlando Immunology Center
NCT03205917Phase 1Oct 23, 2017Harvard University, International AIDS Vaccine Initiative, Ragon Institute of MGH, MIT and Harvard
NCT02960581Phase 1Nov 1, 2016Harvard University, International AIDS Vaccine Initiative, Ragon Institute of MGH, MIT and Harvard
Showing 13 of 13 trials
Page 1 / 1

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institute of Allergy and Infectious Diseases (NIAID)Government11822018
Harvard UniversityAcademic/Hospital5122016
International AIDS Vaccine InitiativeAcademic/Hospital3322016
National Institutes of Health (NIH)Government3022021
Department of Health and Human ServicesGovernment2022021
Emory UniversityAcademic/Hospital2012020
HIV Vaccine Trials NetworkAcademic/Hospital2112020
Orlando Immunology CenterAcademic/Hospital2012018
Ragon Institute of MGH, MIT and HarvardAcademic/Hospital2012016
University of North Carolina at Chapel HillAcademic/Hospital2012020
Centre for the AIDS Programme of Research in South AfricaGovernment1012021
Columbia UniversityAcademic/Hospital1012019
George Washington UniversityAcademic/Hospital1012021
HIV Prevention Trials NetworkAcademic/Hospital1012020
Janssen Pharmaceutica NVFor profit1012021
Monogram BiosciencesFor profit1012026
National Institute of Mental Health (NIMH)Government1012024
University of California, IrvineAcademic/Hospital1012024
University of Texas at HoustonAcademic/Hospital1012021
19 organizations
Page 1 / 1